Dynarrestin
Dynarrestin is an aminothiazole inhibitor of cytoplasmic dynein (cytoplasmic dynein) 1 and 2 and can be used to probe cytoplasmic dynein-dependent cellular processes. Dynarrestin rapidly and reversibly inhibits dynamin-1-driven microtubule sliding in vitro and disrupts mitosis by inducing spindles. Dynarrestin does not affect ATP hydrolysis and interferes with ciliogenesis. Dynarrestin inhibits hedgehog (Hh) -dependent proliferation of neuronal precursors and tumor cells.
Product Specifications
CAS Number
2222768-84-3
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Hedgehog
Type
Reference compound
Related Pathways
Stem Cell/Wnt
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dynarrestin.html
Purity
98.18
Solubility
DMSO : 83.33 mg/mL (ultrasonic)
Smiles
O=C(C1=C(C2=CC=C(N(CC)CC)C=C2)N=C(NC3=CC=C(F)C=C3F)S1)OCC
Molecular Formula
C22H23F2N3O2S
Molecular Weight
431.50
Precautions
H302, H315, H319, H335
References & Citations
[1]Höing S, et al. Dynarrestin, a Novel Inhibitor of Cytoplasmic Dynein. Cell Chem Biol. 2018 Apr 19;25 (4) :357-369.e6.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human Lambda Light Chain (LcN-2 + ICO-106), CF640R conjugate, 0.1mg/mL
Alpha 1 antitrypsin Recombinant Rabbit monoclonal Antibody
